The FDA should study stem-cell treatments – Washington Post
|
The FDA should study stem–cell treatments
Washington Post Regarding the Sept. 13 front-page article “Stem–cell clinics face new scrutiny from FDA”: The Food and Drug Administration should monitor stem–cell clinics and ask for permission to collect data to better make decisions regarding regulation. There is … |
